Comparison 25. PERPHENAZINE vs THIOPROPRAZATE.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Leaving the study early: 1. Any reason	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	0.73 [0.43, 1.22]
2 Leaving the study early: 2. Due to adverse events	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
2.1 short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	2.0 [0.19, 21.40]
3 Adverse events: Movement disorders	1		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
3.1 akathisia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	7.0 [0.89, 54.94]
3.2 akinesia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	0.0 [0.0, 0.0]
3.3 dyskinesia ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	5.0 [0.25, 101.73]
3.4 parkinsonism ‐ short term	1	106	Risk Ratio (M‐H, Random, 95% CI)	2.67 [0.75, 9.51]